Skip to content

NaturaGrez: what changed

What changed

NaturaGrez

BE 0536.436.922
NACE 47.741, Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
filed annual accounts (NBB)
Financial years compared with
Net result for the year
-€1,206
2024 · -€26,245+€25,039
Equity
-€106,489
2024 · -€105,283-€1,206
Cash
€1,135
2024 · €2,242-€1,107
Balance sheet total
€1,796
2024 · €3,015-€1,219

Largest movements

2024 to 2025
Assets
  • Cash -€1,107

    down €1,107 (-49.4%), from €2,242 to €1,135

    mainly Trade debts (-€2,513) and Net result for the year (-€1,206)

  • Financial fixed assets -€100

    no longer reported in 2025 (was €100)

Equity and liabilities
  • Trade debts -€2,513

    down €2,513 (-84.6%), from €2,970 to €457

  • Other debts +€2,500

    up €2,500 (+2.4%), from €105,328 to €107,828

  • Profit (loss) carried forward -€1,206

    down €1,206 (-0.5%), from -€225,283 to -€226,489

Income statement
  • Staff costs -€16,344

    no longer reported in 2025 (was €16,344)

  • Other operating charges -€8,824

    down €8,824 (-94.8%), from €9,304 to €480

  • Gross operating margin -€474

    down €474 (-37.6%), from -€1,263 to -€1,738

  • Financial income +€275

    up €275 (+28.1%), from €981 to €1,256

  • Financial charges -€70

    down €70 (-22.2%), from €315 to €245

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€26,245
Gross operating margin -€474
Staff costs +€16,344
Other operating charges +€8,824
Financial income +€275
Financial charges +€70
Result 2025 -€1,206
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€1,207
Investment +€100
Financing €0
Cash 2024 €2,242
Net result for the year -€1,206
Receivables within one year +€12
Trade debts -€2,513
Other debts +€2,500
Investment in fixed assets (net) +€100
Cash 2025 €1,135
brings cash intakes cash out
Every line side by side 28 lines
Line Code 2024 2025 Change %
Total assets 20/58 €3,015 €1,796 -€1,219 -40.4%
Fixed assets 21/28 €100 - -€100
Financial fixed assets 28 €100 - -€100
Current assets 29/58 €2,915 €1,796 -€1,119 -38.4%
Amounts receivable within one year 40/41 €673 €661 -€12 -1.8%
Trade receivables 40 €9 €403 +€394 +4,375%
Other amounts receivable 41 €664 €259 -€406 -61.1%
Cash at bank and in hand 54/58 €2,242 €1,135 -€1,107 -49.4%
Total equity and liabilities 10/49 €3,015 €1,796 -€1,219 -40.4%
Equity 10/15 -€105,283 -€106,489 -€1,206 -1.1%
Contributions 10/11 €120,000 €120,000 = 0.0%
Profit (loss) carried forward 14 -€225,283 -€226,489 -€1,206 -0.5%
Amounts payable 17/49 €108,298 €108,285 -€13 0.0%
Amounts payable within one year 42/48 €108,298 €108,285 -€13 0.0%
Trade debts 44 €2,970 €457 -€2,513 -84.6%
Suppliers 440/4 €2,970 €457 -€2,513 -84.6%
Other amounts payable 47/48 €105,328 €107,828 +€2,500 +2.4%
Remuneration, social security and pensions 62 €16,344 - -€16,344
Other operating charges 640/8 €9,304 €480 -€8,824 -94.8%
Gross operating margin 9900 -€1,263 -€1,738 -€474 -37.6%
Operating profit (loss) 9901 -€26,911 -€2,217 +€24,694 +91.8%
Financial income 75/76B €981 €1,256 +€275 +28.1%
Recurring financial income 75 €981 €1,256 +€275 +28.1%
Financial charges 65/66B €315 €245 -€70 -22.2%
Recurring financial charges 65 €315 €245 -€70 -22.2%
Profit (loss) for the period before taxes 9903 -€26,245 -€1,206 +€25,039 +95.4%
Profit (loss) for the period 9904 -€26,245 -€1,206 +€25,039 +95.4%
Profit (loss) for the period to be appropriated 9905 -€26,245 -€1,206 +€25,039 +95.4%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.